BioNTech (BNTX) Short Interest Ratio & Short Volume $120.01 +2.13 (+1.81%) Closing price 04:00 PM EasternExtended Trading$122.39 +2.38 (+1.98%) As of 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends BioNTech Short Interest DataBioNTech (BNTX) has a short interest of 2.74 million shares. This marks a 3.79% increase in short interest from the previous month. The short interest ratio (days to cover) is 3.3, indicating that it would take 3.3 days of the average trading volume of 746,687 shares to cover all short positions.Current Short Interest2,740,000 sharesPrevious Short Interest2,640,000 sharesChange Vs. Previous Month+3.79%Dollar Volume Sold Short$339.13 millionShort Interest Ratio3.3 Days to CoverLast Record DateJanuary 31, 2025Outstanding Shares239,740,000 sharesPercentage of Shares Shorted1.14%Today's Trading Volume1,362,383 sharesAverage Trading Volume746,687 sharesToday's Volume Vs. Average182% Short Selling BioNTech? Sign up to receive the latest short interest report for BioNTech and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartBNTX Short Interest Over TimeBNTX Days to Cover Over TimeBNTX Percentage of Float Shorted Over Time BioNTech Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 1/31/20252,740,000 shares $339.13 million +3.8%N/A3.3 $123.77 1/15/20252,640,000 shares $300.09 million +3.5%N/A3.2 $113.67 12/31/20242,550,000 shares $290.57 million +9.4%N/A3.2 $113.95 12/15/20242,330,000 shares $280.49 million -1.3%N/A2.8 $120.38 11/30/20242,360,000 shares $279.40 million -4.5%N/A2.1 $118.39 11/15/20242,470,000 shares $246.31 million +22.3%N/A2.2 $99.72 10/31/20242,020,000 shares $228.46 million -16.2%N/A2 $113.10 10/15/20242,410,000 shares $283.25 million +29.6%1.0%2.5 $117.53 9/30/20241,860,000 shares $220.91 million -30.6%0.8%1.9 $118.77 9/15/20242,680,000 shares $330.71 million +3.9%1.1%2.8 $123.40 Get the Latest News and Ratings for BNTX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for BioNTech and its competitors with MarketBeat's FREE daily newsletter. 8/31/20242,580,000 shares $227.61 million -16.5%1.1%3.7 $88.22 8/15/20243,090,000 shares $269.60 million -1.6%1.3%4.1 $87.25 7/31/20243,140,000 shares $270.67 million -6.8%1.3%4.2 $86.20 7/15/20243,370,000 shares $283.92 million +0.3%1.4%4.7 $84.25 6/30/20243,360,000 shares $270.01 million +22.6%1.4%4.4 $80.36 6/15/20242,740,000 shares $252.30 million -9.9%1.2%3.8 $92.08 5/31/20243,040,000 shares $305.82 million -11.1%1.3%4.1 $100.60 5/15/20243,420,000 shares $315.32 million -7.3%1.4%5.1 $92.20 4/30/20243,690,000 shares $327.75 million +16.8%1.6%6.2 $88.82 4/15/20243,160,000 shares $277.73 million +2.6%1.3%5 $87.89 3/31/20243,080,000 shares $284.13 million No Change1.3%4.7 $92.25 3/15/20243,080,000 shares $284.84 million +5.5%1.3%4.5 $92.48 2/29/20242,920,000 shares $259.76 million -3.0%1.2%4.1 $88.96 2/15/20243,010,000 shares $279.66 million -0.3%1.3%4.3 $92.91 1/31/20243,020,000 shares $287.02 million -5.3%1.3%4.4 $95.04 1/15/20243,190,000 shares $330.39 million +16.0%1.3%4.3 $103.57 12/31/20232,750,000 shares $290.24 million -20.1%1.2%3.8 $105.54 12/15/20233,440,000 shares $351.57 million +14.3%1.5%4.8 $102.20 11/30/20233,010,000 shares $302.23 million +13.2%1.3%4.6 $100.41 11/15/20232,660,000 shares $267.89 million -18.4%1.1%4.2 $100.71 10/31/20233,260,000 shares $304.94 million +38.1%N/A4.5 $93.54 10/15/20232,360,000 shares $244.45 million -8.9%N/A3.1 $103.58 9/30/20232,590,000 shares $281.38 million -6.5%N/A3.8 $108.64 9/15/20232,770,000 shares $313.18 million +13.5%N/A4.2 $113.06 8/31/20232,440,000 shares $295.07 million +15.6%N/A3.5 $120.93 8/15/20232,110,000 shares $223.03 million +18.5%N/A2.9 $105.70 7/31/20231,780,000 shares $193.79 million -1.1%N/A2.4 $108.87 7/15/20231,800,000 shares $194.83 million -9.1%N/A2.6 $108.24 6/30/20231,980,000 shares $213.70 million -15.0%N/A2.9 $107.93 6/15/20232,330,000 shares $263.29 million +14.8%N/A3.3 $113.00Collect $7k per month from Tesla’s SECRET dividend (Ad)There's a little-known secret about Tesla that even seasoned investors don't know. Despite not paying a traditional dividend, there's a way to collect up to $7,013 per month from Tesla… starting as early as next month. This backdoor strategy is changing the game for smart investors. Want to see how it works?Click here to uncover Tesla's hidden income secret. 5/31/20232,030,000 shares $213.31 million +0.5%N/A2.9 $105.08 5/15/20232,020,000 shares $217.96 million +5.2%N/A2.9 $107.90 4/30/20231,920,000 shares $219.34 million -5.0%N/A3 $114.24 4/15/20232,020,000 shares $261.91 million +6.9%N/A3.3 $129.66 3/31/20231,890,000 shares $235.44 million +5.6%N/A2.9 $124.57 3/15/20231,790,000 shares $232.59 million -8.7%N/A2.6 $129.94 2/28/20231,960,000 shares $254.90 million +32.4%N/A2.5 $130.05 2/15/20231,480,000 shares $218.48 million -23.7%N/A1.8 $147.62 1/31/20231,940,000 shares $278.22 million +23.6%N/A2.2 $143.41 1/15/20231,570,000 shares $227.73 million +7.5%N/A1.6 $145.05 12/30/20221,460,000 shares $219.32 million +4.3%N/A1.5 $150.22 12/15/20221,400,000 shares $254.86 million -15.7%N/A1.5 $182.04 11/30/20221,660,000 shares $277.25 million -11.7%N/A1.8 $167.02 11/15/20221,880,000 shares $307.81 million -12.2%N/A2.2 $163.73 10/31/20222,140,000 shares $294.55 million -3.2%N/A2.5 $137.64 10/15/20222,210,000 shares $299.72 million -32.0%N/A2.5 $135.62 9/30/20223,250,000 shares $438.36 million +12.9%N/A3.8 $134.88 9/15/20222,880,000 shares $415.12 million +56.5%N/A3 $144.14 8/31/20221,840,000 shares $266.14 million -5.2%N/A1.8 $144.64 8/15/20221,940,000 shares $315.21 million +4.3%N/A1.8 $162.48 7/31/20221,860,000 shares $307.18 million -11.0%N/A1.6 $165.15 7/15/20222,090,000 shares $337.41 million +9.4%N/A1.8 $161.44 6/30/20221,910,000 shares $284.78 million -1.0%N/A1.5 $149.10 6/15/20221,930,000 shares $266.32 million -3.5%N/A1.4 $137.99 5/31/20222,000,000 shares $326.72 million -7.4%N/A1.3 $163.36 5/15/20222,160,000 shares $343.09 million +7.5%N/A1.4 $158.84 4/30/20222,010,000 shares $278.95 million -16.3%N/A1.3 $138.78 4/15/20222,400,000 shares $420.70 million -5.9%N/A1.3 $175.29 3/31/20222,550,000 shares $434.93 million -16.1%N/A1.2 $170.56 3/15/20223,040,000 shares $440.92 million +8.6%N/A1.4 $145.04 2/28/20222,800,000 shares $422.27 million +5.3%N/A1.2 $150.81 2/15/20222,660,000 shares $434.75 million +33.0%N/A0.9 $163.44 1/31/20222,000,000 shares $344.16 million -1.0%N/A0.6 $172.08 1/15/20222,020,000 shares $395.92 million -6.5%N/A0.6 $196.00 12/31/20212,160,000 shares $556.85 million -0.5%N/A0.7 $257.80 12/15/20212,170,000 shares $622.90 million -5.2%N/A0.6 $287.05 11/30/20212,290,000 shares $805.48 million -28.2%N/A0.7 $351.74 11/15/20213,190,000 shares $799.03 million +25.1%N/A1 $250.48 10/29/20212,550,000 shares $710.76 million +0.4%N/A0.7 $278.73 10/15/20212,540,000 shares $629.11 million +10.9%N/A0.6 $247.68 9/30/20212,290,000 shares $625.15 million -2.6%N/A0.5 $272.99 9/15/20212,350,000 shares $834.84 million +10.9%N/A0.6 $355.25 8/31/20212,120,000 shares $697.88 million +2.4%N/A0.5 $329.19 8/13/20212,070,000 shares $781.05 million +32.7%N/A0.5 $377.32 7/30/20211,560,000 shares $512.23 million -23.2%N/A0.5 $328.35 7/15/20212,030,000 shares $448.79 million -9.0%N/A0.7 $221.08 6/30/20212,230,000 shares $499.25 million -21.5%N/A0.7 $223.88 6/15/20212,840,000 shares $619.60 million -8.4%N/A0.9 $218.17 5/28/20213,100,000 shares $632.40 million -18.6%N/A1.1 $204.00 5/14/20213,810,000 shares $688.81 million -0.5%1.6%1.4 $180.79Collect $7k per month from Tesla’s SECRET dividend (Ad)There's a little-known secret about Tesla that even seasoned investors don't know. Despite not paying a traditional dividend, there's a way to collect up to $7,013 per month from Tesla… starting as early as next month. This backdoor strategy is changing the game for smart investors. Want to see how it works?Click here to uncover Tesla's hidden income secret. 4/30/20213,830,000 shares $688.06 million -19.4%1.6%1.5 $179.65 4/15/20214,750,000 shares $629.85 million -0.2%2.0%2.4 $132.60 3/31/20214,760,000 shares $497.13 million +25.3%2.0%2.5 $104.44 3/15/20213,800,000 shares $392.46 million +4.7%1.6%1.8 $103.28 2/26/20213,630,000 shares $407.76 million -1.9%1.5%1.3 $112.33 2/12/20213,700,000 shares $436.71 million -20.9%1.5%1.1 $118.03 1/29/20214,680,000 shares $514.80 million -28.8%1.9%1.2 $110.00 1/15/20216,570,000 shares $695.43 million +11.7%2.7%1.6 $105.85 12/31/20205,880,000 shares $493.57 million -7.4%2.4%1.5 $83.94 12/15/20206,350,000 shares $687.51 million -9.7%2.6%1.6 $108.27 11/30/20207,030,000 shares $773.23 million +13.9%2.9%2 $109.99 11/15/20206,170,000 shares $654.02 million +1.3%2.6%2 $106.00 10/30/20206,090,000 shares $516.49 million -6.3%N/A2.3 $84.81 10/15/20206,500,000 shares $564.59 million -2.4%N/A2.4 $86.86 9/30/20206,660,000 shares $461.07 million +13.1%N/A1.9 $69.23 9/15/20205,890,000 shares $394.16 million +15.0%N/A1.6 $66.92 8/31/20205,120,000 shares $313.60 million +33.0%N/A1.5 $61.25 8/14/20203,850,000 shares $264.26 million -25.7%N/A1.2 $68.64 7/31/20205,180,000 shares $425.33 million +36.7%N/A1.7 $82.11 7/15/20203,790,000 shares $295.62 million +15.6%N/A1.4 $78.00 6/30/20203,280,000 shares $218.91 million +7.2%N/A1.8 $66.74 6/15/20203,060,000 shares $155.60 million +31.3%N/A2.2 $50.85 5/29/20202,330,000 shares $115.40 million +19.5%N/A1.7 $49.53 5/15/20201,950,000 shares $96.51 million +15.4%N/A1.6 $49.49 4/30/20201,690,000 shares $80.24 million +21.6%N/A1.8 $47.48 4/15/20201,390,000 shares $53.63 million -10.3%N/A1.8 $38.58 3/31/20201,550,000 shares $74.01 million +35.6%N/A3.5 $47.75 3/13/20201,143,100 shares $51.91 million -21.2%N/A6.4 $45.41 2/28/20201,450,000 shares $74.40 million -3.3%N/A6.3 $51.31 BNTX Short Interest - Frequently Asked Questions What is BioNTech's current short interest? Short interest is the volume of BioNTech shares that have been sold short but have not yet been closed out or covered. As of January 31st, investors have sold 2,740,000 shares of BNTX short. Learn More on BioNTech's current short interest. What is a good short interest ratio for BioNTech? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. BNTX shares currently have a short interest ratio of 3.0. Learn More on BioNTech's short interest ratio. Which institutional investors are shorting BioNTech? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of BioNTech: Wolverine Trading LLC, Squarepoint Ops LLC, Torno Capital LLC, Millennium Management LLC, LMR Partners LLP, Group One Trading LLC, D. E. Shaw & Co. Inc., Caption Management LLC, Citadel Advisors LLC, Balyasny Asset Management L.P., Jane Street Group LLC, Parallax Volatility Advisers L.P., Two Sigma Securities LLC, Susquehanna International Group LLP, Concourse Financial Group Securities Inc., Walleye Trading LLC, Walleye Capital LLC, Barclays PLC, Capital Fund Management S.A., JPMorgan Chase & Co., Twin Tree Management LP, IMC Chicago LLC, and JPMorgan Chase & Co.. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. Is BioNTech's short interest increasing or decreasing? BioNTech saw a increase in short interest in January. As of January 31st, there was short interest totaling 2,740,000 shares, an increase of 3.8% from the previous total of 2,640,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does BioNTech's short interest compare to its competitors? Here is how the short interest of companies in the industry of "pharmaceutical products" compare to BioNTech: GSK plc (0.85%), Takeda Pharmaceutical Company Limited (0.12%), argenx SE (3.32%), Teva Pharmaceutical Industries Limited (1.97%), Summit Therapeutics Inc. (2.83%), Genmab A/S (0.26%), Intra-Cellular Therapies, Inc. (1.50%), Viatris Inc. (2.60%), Moderna, Inc. (11.84%), Dr. Reddy's Laboratories Limited (1.90%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: AppLovin Co. ($5.21 billion), Charter Communications, Inc. ($4.07 billion), Reddit, Inc. ($3.33 billion), The Kroger Co. ($2.67 billion), Cencora, Inc. ($2.29 billion), Hims & Hers Health, Inc. ($2.17 billion), SoFi Technologies, Inc. ($1.99 billion), Live Nation Entertainment, Inc. ($1.87 billion), Rivian Automotive, Inc. ($1.76 billion), and Moderna, Inc. ($1.60 billion). View all of the most shorted stocks. What does it mean to sell short BioNTech stock? Short selling BNTX is an investing strategy that aims to generate trading profit from BioNTech as its price is falling. BNTX shares are trading up $2.13 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against BioNTech? A short squeeze for BioNTech occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of BNTX, which in turn drives the price of the stock up even further. How often is BioNTech's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including BNTX, twice per month. The most recent reporting period available is January, 31 2025. More Short Interest Resources from MarketBeat Related Companies GSK Short Interest TAK Short Interest ARGX Short Interest TEVA Short Interest SMMT Short Interest GMAB Short Interest ITCI Short Interest VTRS Short Interest MRNA Short Interest RDY Short Interest Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:BNTX) was last updated on 2/21/2025 by MarketBeat.com Staff From Our PartnersCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredElon “obliterates” Bill Gates?All 10 of the world's biggest money managers follow my work, and the Pentagon, the FBI and Harvard professors ...Altimetry | SponsoredNVDA Crash UpdateAn overseas AI rival sent shockwaves through the U.S. tech market last week... Leaving millions of investor...Chaikin Analytics | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | Sponsored Is Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again ...Paradigm Press | Sponsored My 2025 AI BlueprintI first recommended Bitcoin at $300 in 2013 … before it went up 33,645%. Now, I am revealing my 2025 AI Blu...Weiss Ratings | SponsoredBuy this AI Stock Before Elon’s AnnouncementWith Trump back in office, xAI is primed to become the leader in generative AI, leaving competitors in the dus...InvestorPlace | SponsoredElon’s “New Gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding BioNTech SE Please log in to your account or sign up in order to add this asset to your watchlist. Share BioNTech With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.